A group of scientists in Japan has discovered that fermented stevia, a plant commonly used as a calorie-free sweetener, may ...

Progression-free and overall survival were greater in relacorilant plus nab-paclitaxel compared to nab-paclitaxel alone. 2. The rate of adverse events was comparable between groups. Evidence Rating ...

A new exploratory analysis of the HIMALAYA phase III trial involving patients with unresectable hepatocellular carcinoma ...

Detailed price information for Corcept Therapeutics (CORT-Q) from The Globe and Mail including charting and trades.

PURPOSEGEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment ...

Panelists discuss how current NCCN guidelines for metastatic anal cancer recommend carboplatin-paclitaxel as preferred first-line therapy, with the recent addition of carboplatin-paclitaxel plus ...

This new article publication from Acta Pharmaceutica Sinica B, discusses targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by ...

Liver cancer, the advanced stage of various chronic liver diseases, has garnered attention due to its high incidence and insidious progression. Lipid droplets (LDs), unique lipid storage organelles in ...

Is transarterial (chemo)embolisation better than systemic chemotherapy for treating bowel cancer that has spread to the liver?

The researchers then treated the models with pitavastatin, a statin drug, to suppress the expression of IL-33. This treatment was effective in reducing the risk of chronic hepatitis and liver cancer.

Limiting carcinogen exposure or taking a statin drug could lower liver inflammation and cancer risk associated with HBV infection   ...